Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
 Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, NC

Trial Information

54 week study for patients with COPD who have had at least 1 breathing exacerbation in the past 12 months

The purpose of this study is to evaluate the long-term safety use of Perforomist in patients with COPD

Patient Inclusion Criteria:

  • Age 40+
  • Smoking history of at least 10 pack years
  • 1 documented breathing exacerbation within the past 12 months

Patient Exclusion Criteria:

  • Prior use of Perforomist
  • Currently using oxygen therapy 12+ hours each day
  • Breathing exacerbation within the past 30 days
  • Current use of non-specific beta blockers, tricyclic antidepressants, leukotrine modifiers, theophylline

Mary Preisel, Marketing/Clinical Research Coordinator
American Health Research
1918 Randolph Rd, Suite 440
Charlotte, NC 28207
Phone: 704-325-6700
Email: Mpreisel@ahres.com

View Map

Research Center Information: American Health Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.